AKR1C3-IN-17
AKR1C3-IN-17 is a cathepsin B (CTSB)-activated small molecule-drug conjugate targeting AKR1C3 with an IC50 of 9 nM. AKR1C3-IN-17 is cleaved by CTSB to release the payload Gemcitabine (HY-17026). AKR1C3-IN-17 induces apoptosis and shows antitumor activity in mice. AKR1C3-IN-17 can be used for the study of hepatocellular carcinoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3120497-79-9
- Formel: C38H43F2N7O11
- Molecular Weight:811.79
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Cathepsin Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | IC50 |
1.60 μM
|
Inhibits the proliferation of HepG2 cells
Inhibits the proliferation of HepG2 cells
|
42470376 |
In Vitro
AKR1C3-IN-17 (compound SM-27) (250 nM-1 μM; 24 h) induces cell cycle arrest at the S phase in HepG2 cells in a dose-dependent manner[1].
AKR1C3-IN-17 (250 nM-1 μM; 24 h) induces apoptosis in HepG2 cells in a dose-dependent manner, with total apoptotic rates of 1.34% (at 250 nM), 6.32% (at 500 nM) and 17.17% (at 1 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HepG2
-
Concentration:250 nM, 500 nM, 1 μM
-
Incubation Time:24 h
-
Result:Induced cell cycle arrest at S phase in a dose-dependent manner.
-
Cell Line:HepG2
-
Concentration:250 nM, 500 nM, 1 μM
-
Incubation Time:24 h
-
Result:Induced apoptosis in a dose-dependent manner; total apoptotic rates were 1.34%, 6.32%, and 17.17%, respectively.
Parmacokinetics
| Species | Dose | Route | T1/2 | CLz | AUC0-t | AUC0-∞ | MRT0-t | MRT0-∞ | Tmax | Vz | Cmax | Vz/F | CLz/F | F |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rat[1] | 2 mg/kg | i.v. | 3.45 h | 0.02 L/h/kg | 182.41 h·μg/L | 227.95 h·μg/L | 4.00 h | 5.28 h | 0.05 h | 0.06 L/kg | 47.60 μg/mL | / | / | / |
| Rat[1] | 5 mg/kg | i.g. | 4.27 h | / | 254.81 μg/L·h | 260.34 μg/L·h | 5.99 h | 6.72 h | 1.00 h | / | 33.65 μg/mL | 0.14 L/kg | 0.02 L/h/kg | 45.68 % |
In Vivo
AKR1C3-IN-17 (5 mg/kg; i.g.; q.d.; for 31 days) shows antitumor activity in the HepG2 mouse xenograft model, with a TGI of 60.24%[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:
-
Dosage:2 mg/kg (i.v.); 5 mg/kg (i.g.)
-
Administration:i.v. or i.g.; q.d. for 31 days
-
Result:Showed significant antitumor activity with TGI of 76.27% (i.v., 2 mg/kg) and 60.24% (i.g., 5 mg/kg).
No significant body weight loss was observed in all treatment groups.
Revealed no significant damage to heart, liver, spleen, lung, and kidney.
Chemical Information
-
CAS. Nr. 3120497-79-9
-
Molecular Weight 811.79
-
Formel C38H43F2N7O11
-
SMILES
COC1=CC(C(N[C@@H](C(C)C)C(N[C@H](C(NC2=NC(N(C=C2)[C@@H]3O[C@@H]([C@H](C3(F)F)O)CO)=O)=O)C)=O)=O)=CC(NC(C4=CC=CC=C4OCC5=C(ON=C5C)C)=O)=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Subcutaneous Cell-Line-Derived Xenograft
Subcutaneous cell-line-derived xenograft (CDX) models are established by implanting cultured human cancer cell lines into immunodeficient mice, where the injected cells form localized tumors that can be monitored in vivo as a measure of tumorigenic potential, growth kinetics, and treatment response. These models are widely used in oncology research because they allow reproducible tumor formation and enable comparative assessment of tumor growth between different cell lines or genetic manipulations in a controlled in vivo microenvironment. Subcutaneous implantation of cancer cells in immunodeficient mice is a standard approach for evaluating tumor growth behavior and therapeutic response across multiple cancer types, including prostate, esophageal, pancreatic, and colon cancer models.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)